Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer

BACKGROUND: The axillary pathologic complete response rate (pCR) and the effect of axillary pCR on disease-free survival (DFS) was determined in patients with HER2-positive breast cancer and biopsy-proven axillary lymph node metastases who were receiving concurrent trastuzumab and neoadjuvant chemot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer
Main Authors: Dominici, Laura S., Gonzalez, Viviana M. Negron, Buzdar, Aman U., Lucci, Anthony, Mittendorf, Elizabeth A., Le-Petross, Huong T., Babiera, Gildy V., Meric-Bernstam, Funda, Hunt, Kelly K., Kuerer, Henry M.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4361091/
https://ncbi.nlm.nih.gov/pubmed/20564395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25152
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares